US 8895591
Tricyclic compound and pharmaceutical use thereof
granted A61KA61K31/423A61K31/428
Quick answer
US patent 8895591 (Tricyclic compound and pharmaceutical use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/423, A61K31/428, A61P, A61P25/00